This novel study reveals a promising treatment strategy to overcome apoptosis resistance in KRAS-mutant colorectal cancer by concurrent upregulation of Noxa/Bik and antagonism of Bcl-xL.
No takes yet. Share an insight, caveat, or question.
Okamoto et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: